These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Activities of transport adenosine triphosphatases in erythrocyte membranes of healthy and hypertensive subjects. Lin SJ; Hong CY; Chiang BN; Wei YH Clin Exp Hypertens A; 1985; 7(8):1151-63. PubMed ID: 2994917 [TBL] [Abstract][Full Text] [Related]
6. Red blood cell calmodulin and Ca2+ pump ATPase: preliminary results of a species comparison. Vincenzi FF Prog Clin Biol Res; 1981; 55():363-83. PubMed ID: 6117080 [TBL] [Abstract][Full Text] [Related]
7. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension. Fu Y; Wang S; Lu Z; Li H; Li S Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376 [TBL] [Abstract][Full Text] [Related]
8. Erythrocyte calcium-stimulated, magnesium-activated adenosine 5'-triphosphatase activity in essential hypertension. Adeoya AS; Bing RF; Norman RI J Hypertens; 1992 Jul; 10(7):651-6. PubMed ID: 1321192 [TBL] [Abstract][Full Text] [Related]
10. Trifluoperazine inhibition of calmodulin-sensitive Ca2+ -ATPase and calmodulin insensitive (Na+ +K+)- and Mg2+ -ATPase activities of human and rat red blood cells. Luthra MG Biochim Biophys Acta; 1982 Nov; 692(2):271-7. PubMed ID: 6128998 [TBL] [Abstract][Full Text] [Related]
11. Action of long-chain fatty acids in vitro on Ca2+-stimulatable, Mg2+-dependent ATPase activity in human red cell membranes. Davis FB; Davis PJ; Blas SD; Schoenl M Biochem J; 1987 Dec; 248(2):511-6. PubMed ID: 2963620 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of basal and calmodulin-activated Ca2+-pump ATPase by fractionated compound 48/80. Di Julio D; Hinds TR; Vincenzi FF Biochim Biophys Acta; 1989 Jun; 981(2):337-42. PubMed ID: 2525052 [TBL] [Abstract][Full Text] [Related]
14. Calmodulin and the plasma membrane calcium pump. Vincenzi FF; Hinds TR; Raess BU Ann N Y Acad Sci; 1980; 356():232-44. PubMed ID: 6112944 [TBL] [Abstract][Full Text] [Related]
15. [Changes of Ca2(+)-ATPase and calmodulin in erythrocytes and their responses to nifedipine in essential hypertension]. Song K Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):260-1, 318. PubMed ID: 2150803 [TBL] [Abstract][Full Text] [Related]
16. The nature of the Ca2+-pump defect in the red blood cells of patients with cystic fibrosis. Muallem S; Miner C; Seymour CA Biochim Biophys Acta; 1985 Sep; 819(1):143-7. PubMed ID: 2931115 [TBL] [Abstract][Full Text] [Related]
17. Comparison of erythrocyte membrane Ca2(+)-Mg2(+)-ATPase activity in children with and without family history of essential hypertension. Cheng HY; Liu LS; Zheng DY J Hum Hypertens; 1990 Apr; 4(2):147-8. PubMed ID: 2140135 [TBL] [Abstract][Full Text] [Related]
19. Verapamil, diltiazem and nifedipine interactions with calmodulin stimulated (Ca2+ + Mg2+)-ATPase. Kim HC; Raess BU Biochem Pharmacol; 1988 Mar; 37(5):917-20. PubMed ID: 2964236 [TBL] [Abstract][Full Text] [Related]
20. [The Ca pump and Ca ATPase in the erythrocytes of patients with hypertension: disorders detected in cytoskeletal membranes and in solubilized Ca ATPase]. Pokudin NI; Orlov SN; Postnov IuV Kardiologiia; 1986 Mar; 26(3):94-9. PubMed ID: 2423739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]